Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2010
04/06/2010US7692023 Candesartan cilexetil polymorphs
04/06/2010US7692022 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations
04/06/2010US7692005 Kinase inhibitors
04/06/2010US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability
04/06/2010US7691892 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
04/06/2010US7691885 Pyridones useful as inhibitors of kinases
04/06/2010US7691870 N-[4-(pyridine-4-yloxy)phenyl]-4-bromo-6-tefluoromethyl-1H-benzimidazole-2-carboxamide; for cancerous cell growth mediated by one or more raf-kinases
04/06/2010US7691867 Chemical compounds
04/06/2010US7691866 Anticancer agents
04/06/2010US7691861 Indolymaleimide derivatives
04/06/2010US7691855 {4-[3-(2,3-dimethyl-phenyl)-1H-pyrazol-4-yl]-pyrimidin-2-yl}-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine; antiproliferative agents; tumor
04/06/2010US7691853 Pyrazole compounds useful as protein kinase inhibitors
04/06/2010US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure
04/06/2010US7691841 Azetidine derivatives as CCR-3 receptor antagonist
04/06/2010US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2361057C Quinoline derivatives and quinazoline derivatives
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010WO2010037059A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/01/2010WO2010036921A2 Slow release of organoboronic acids in cross-coupling reactions
04/01/2010WO2010036873A1 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
04/01/2010WO2010036814A1 Selective seprase inhibitors
04/01/2010WO2010036796A1 Pyridineamine derivatives
04/01/2010WO2010036629A2 Fused multicyclic compounds as protein kinase inhibitors
04/01/2010WO2010036613A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
04/01/2010WO2010036000A2 Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010034931A1 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof
04/01/2010WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
04/01/2010WO2010034737A1 Pyrazole compounds for controlling invertebrate pests
04/01/2010WO2010034649A1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases
04/01/2010WO2010017545A3 Triazole compounds that modulate hsp90 activity
04/01/2010WO2010017240A3 Aurora kinase modulators and methods of use
04/01/2010WO2010002655A3 Pyrimidine derivatives as kinase inhibitors
04/01/2010WO2010001042A3 Cosmetic composition, compound, and cosmetic treatment method
04/01/2010WO2009131669A3 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/01/2010US20100081687 Biarylcarboxyarylamides as vanilloid-1 receptor modulators
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081678 Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
04/01/2010US20100081677 Heteroarylamide pyrimidone derivatives
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081665 Anti-Malarial Compounds
04/01/2010US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081653 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
04/01/2010US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
04/01/2010US20100081641 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
04/01/2010US20100081203 Fluorescent isotope tags and their method of use
04/01/2010US20100081071 Colored curable composition, fluorine-containing dipyrromethene compound and tautomer thereof, and fluorine-containing dipyrromethene metal complex and tautomer thereof, and color filter using the same and method for producing the color filter
04/01/2010US20100080786 Phenyl or Pyridinyl Substituted Indazoles Derivatives
04/01/2010CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators
04/01/2010CA2738083A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents
04/01/2010CA2737941A1 Selective seprase inhibitors
04/01/2010CA2737694A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
04/01/2010CA2736538A1 Pyrazole compounds for controlling invertebrate pests
04/01/2010CA2735886A1 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
04/01/2010CA2734472A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
03/2010
03/31/2010EP2169028A2 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
03/31/2010EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168951A1 Azolylmethylenehydrazine derivative and use thereof
03/31/2010EP2167493A1 Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl]-pyrrole-2,5-di one
03/31/2010EP2167492A2 Novel amide derivative for inhibiting the growth of cancer cells
03/31/2010EP2167491A1 5-heteroaryl substituted indazoles as kinase inhibitors
03/31/2010EP2167487A1 Pyrrole derivatives as p2y12 antagonists
03/31/2010EP2167476A2 Novel hiv reverse transcriptase inhibitors
03/31/2010EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP2166849A1 Substituted pyrazole compounds
03/31/2010EP2076496B1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/31/2010CN101687860A Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
03/31/2010CN101687857A Pyridazinone derivates
03/31/2010CN101687856A Co-crystals and pharmaceutical compositions comprising the same
03/31/2010CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687844A Imidazole derivatives as CCR2 receptor antagonists
03/31/2010CN101687843A Substituted aromatic heterocyclic compounds as fungicides
03/31/2010CN101687841A Benzimidazole derivatives
03/31/2010CN101687822A Di(arylamino)aryl compound
03/31/2010CN101687821A protein kinase inhibitors and methods for using thereof
03/31/2010CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
03/31/2010CN101687808A indazolamide derivatives
03/31/2010CN101687801A Ethers of naphtalene carboxylic acid amides as cancer cure
03/31/2010CN101687789A Novel inhibitors hepatitis c virus replication
03/31/2010CN101687788A substituted indoles
03/31/2010CN101684101A Piperazinone substituted tetracycline derivatives
03/31/2010CN101684097A Phenylpyrimidine amines as ige inhibitors
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/30/2010US7687633 shields light having such wavelength that reduces color purity while maintaining brightness in visible field (can reduce tinting caused by extra blue lights); provide clear images; improve colors
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687535 Substituted 3-sulfur indoles
03/30/2010US7687533 N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides
03/30/2010US7687532 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010US7687511 Substituted dihydropyrimidines, dihydropyrimidones and dihydropyrimidinethiones as calcium channel blockers